KEAP1Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes

Title
KEAP1Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume -, Issue -, Pages ji1700812
Publisher
The American Association of Immunologists
Online
2018-01-20
DOI
10.4049/jimmunol.1700812

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started